LENZ Therapeutics News

TD Cowen Sticks to Their Buy Rating for Enliven Therapeutics (ELVN)

TipRanks34minutes ago

Argenica Therapeutics' Neuroprotective Drug ARG-007 Shows Positive Results in Ferret Preclinical Study

A preclinical study found that Argenica Therapeutics' (ASX:AGN) ARG-007 can significantly reduce damage to brain cells, providing further evidence of the potential of the neuroprotective drug as a tre

MT Newswires35minutes ago

UPDATE - SPR Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT PNS Treatment in Relieving Postoperative Knee Pain

Yahoo Finance57minutes ago

Cardiol Therapeutics Reports Q1 Financial Dip

TipRanks18:28 ET

LENZ Therapeutics(LENZ.US) Director Buys US$501.09K in Common Stock

$LENZ Therapeutics(LENZ.US)$ Director MCCOLLUM JAMES W purchased 31,332 shares of common stock on May 13, 2024 at an average price of $15.993 for a total value of $501.09K.Source: Announcement What is

moomoo News18:13 ET

Express News | Tenaya Therapeutics Inc: Cost Containment Measures Including Committed Plan to Reduce Workforce by About 22%, Sees to Be Completed During Q2

Reuters17:34 ET

Tenaya Therapeutics Cutting Workforce by 22%

By Paul Ziobro Tenaya Therapeutics is reducing its workforce by about 22%, as it looks to cut costs and focus on clinical trials for heart-disease therapies. The South San Francisco, Calif.-based bi

WSJ17:17 ET

Express News | Vivos Therapeutics Shares Are Trading Lower After the Company Reported a Year-over-year Decrease in Q1 Sales Results

Benzinga17:05 ET

Kintara Therapeutics Announces Upcoming Merger With TuHURA Biosciences

TipRanks17:03 ET

Express News | Lineage Cell Therapeutics Inc: Prospectus Related to Offer of Common Shares From Time to Time Having Offering Price of up to $40.0 Mln Through Agent

Reuters16:57 ET

Viracta Therapeutics Welcomes New CFO and Outlines Compensation

TipRanks16:52 ET

Express News | Kintara Therapeutics Inc - Qtrly Shr Loss $0.05

Reuters16:52 ET

Express News | Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results

Reuters16:45 ET

Express News | Allogene Therapeutics Files For Offering Of Up To 37.93M Shares Of Common Stock

Benzinga16:43 ET

United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing

Martine A Rothblatt, Director, Chairperson & CEO, on May 10, 2024, sold 7,200 shares in United Therapeutics (UTHR) for $1,911,532. Following the Form 4 filing with the SEC, Rothblatt has control over

MT Newswires16:39 ET

Express News | Allogene Therapeutics Inc Files for Offering of up to 37.93 Mln of Common Stock - SEC Filing

Reuters16:39 ET

Express News | Serina Therapeutics Q1 2024 R&D Expenses $1.1M Vs $400K Prior

Benzinga16:34 ET

Express News | Qualigen Therapeutics Files for Non-Timely 10-Q With U.S. SEC

Reuters16:34 ET

Express News | Poseida Therapeutics Inc: Expects Current Cash, Cash Equivalents and Short-Term Investments Sufficient to Fund Operations Into Second Half of 2025

Reuters16:34 ET

Express News | Tenaya Therapeutics- Expects Current Cash, Cash Equivalents and Investments in Marketable Securities to Be Sufficient to Fund Co Into H2 of 2025

Reuters16:30 ET